Abstract
Globally the devastating consequence of COVID-19 or Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV-2) has posed danger on the life of living beings. Doctors and scientists throughout the world are working day and night to combat the proliferation or transmission of this deadly disease in terms of technology, finances, data repositories, protective equipment, and many other services. Rapid and efficient detection of COVID-19 reduces the rate of spreading this deadly disease and early treatment improve the recovery rate. In this paper, we proposed a new framework to exploit powerful features extracted from the autoencoder and Gray Level Co-occurence Matrix (GLCM), combined with random forest algorithm for the efficient and fast detection of COVID-19 using computed tomographic images. The model’s performance is evident from its 97.78% accuracy, 96.78% recall, and 98.77% specificity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The dataset is collected from the web and its link is given below.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
